Biophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for €4 Million
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 30, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris: ALBPS), a...
Day: June 30, 2022
Verisante Technology Inc. Announces Non-Brokered Private Placement
VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Verisante Technology, Inc. (NEX:VER.H) (the "Company") is pleased to announce it...
Highmark Interactive Inc. Grant of Stock Options
TORONTO, ON / ACCESSWIRE / June 30, 2022 / Highmark Interactive Inc. (TSXV:HMRK) a global leader in digital health technologies...
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to...
Canine Biologics Launches Adaptive Liquid Nutrition System for Critically Ill or Injured Dogs & Cats
NutriDapt liquid feeding system provides fast, easy, patient-specific nutrition for veterinary patients who need it mostDENVER, CO / ACCESSWIRE /...
GoodCap Pharmaceuticals Announces Publication of International Patent Application
Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - GoodCap Pharmaceuticals Inc. ("GoodCap"), a biopharmaceutical company developing low-dose psychedelic therapies, is...
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders
CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with...
Melzi Surgical to Participate at the Society of Robotic Surgery 2022 Annual Meeting
Company to showcase the Melzi Sharps Finder, a U.S. FDA registered device designed to locate lost needles and objects for...
9 Meters Biopharma Announces Debt Facility to Support Phase 3 Study of Vurolenatide for Short Bowel Syndrome
Initial Draw of $20 Million to Support Funding Phase 3 Development of Vurolenatide in Short Bowel SyndromeRALEIGH, NC / ACCESSWIRE...
Enlighta Announces Appointment of John F. Wallace and Dr. Christina Gong as Independent Directors
TORTOLA, BVI / ACCESSWIRE / June 30, 2022 / Enlighta Inc. (TSXV:NLTA) ("Enlighta" or the "Company") is pleased to announce...
Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products
Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A EventSOUTH EASTON, MA / ACCESSWIRE / June 30, 2022...
SphingoTec Appoints Jörg Menten as CEO to Accelerate Commercialization and Global Growth
SphingoTec appoints Jörg Menten as Chief Executive Officer (CEO) as from July 1, 2022 to drive the commercialization and scale...
9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome
Phase 2 VIBRANT study identifies a dose and dosing interval with >25% improvement in the primary endpoint of 24-hour mean...
Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis
Lung Cancer Orchestrator June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess...
CISOs Connect Names NRC Health Chief Security and Privacy Officer Among 2022 Top 100 CISOs in the Country
Cris Ewell recognized by second-annual C100 awards for outstanding achievements in the cybersecurity communityLINCOLN, Neb., June 30, 2022 (GLOBE NEWSWIRE)...
Headlands Research Further Expands its Leading Clinical Research Site Network by Acquiring Peninsula Research Associates
SAN FRANCISCO, June 30, 2022 (GLOBE NEWSWIRE) -- Headlands Research announced today the acquisition of Peninsula Research Associates (PRA) of...
BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
Pure Extracts Signs Listing Agreement with Shoppers Drug Mart and Receives Initial Purchase Order
VANCOUVER, British Columbia, June 30, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Agenus to Participate at William Blair’s Biotech Focus Conference
LEXINGTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics...
WIMI Hologram Academy: New smart transportation infrastructure based on Augmented Reality technology
HONG KONG, June 30, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...